Vesale Superbiotics

Belgian company Vésale Pharma specializes in R&D on probiotic solutions, dedicating 23% of turnover to R&D every year as a pioneer in the field, working with major Belgian and international universities and institutes, including the Pasteur Institute of Lille, France, and Texas A&M University, USA. Its products are sold in more than 30 countries worldwide through a network of agents and distributors, and Vésale holds 6 worldwide patents, including Intelicaps, a uniquely revolutionary probiotic micro-encapsulation technology; the company's two main added values are its research-based product range with documented strains and the Intelicaps technology, which dramatically increases the survival of live probiotics through gastric passage, serving as an excellent colonic delivery system that achieves 1,000 times higher survival and availability of live probiotics compared to conventional lyophilized products.